KBC Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $56.8M | Sell |
127,208
-13,912
| -10% | -$6.49M | 0.14% | 139 |
|
|
2025
Q4 | $64M | Buy |
141,120
+7,518
| +6% | +$3.24M | 0.15% | 130 |
|
|
2025
Q3 | $52.3M | Buy |
133,602
+937
| +0.7% | +$392K | 0.13% | 146 |
|
|
2025
Q2 | $59.1M | Buy |
132,665
+13,360
| +11% | +$6.16M | 0.16% | 127 |
|
|
2025
Q1 | $57.8M | Sell |
119,305
-124
| -0.1% | -$57.8K | 0.18% | 132 |
|
|
2024
Q4 | $48.1M | Buy |
119,429
+22,702
| +23% | +$10.5M | 0.13% | 151 |
|
|
2024
Q3 | $45M | Buy |
96,727
+9,685
| +11% | +$4.65M | 0.14% | 153 |
|
|
2024
Q2 | $40.8M | Buy |
87,042
+4,870
| +6% | +$2.11M | 0.12% | 151 |
|
|
2024
Q1 | $34.3M | Sell |
82,172
-19,102
| -19% | -$8.08M | 0.11% | 185 |
|
|
2023
Q4 | $41.2M | Buy |
101,274
+874
| +0.9% | +$323K | 0.15% | 157 |
|
|
2023
Q3 | $34.9M | Sell |
100,400
-116,478
| -54% | -$40.7M | 0.14% | 156 |
|
|
2023
Q2 | $76.3M | Buy |
216,878
+24,800
| +13% | +$8.36M | 0.31% | 71 |
|
|
2023
Q1 | $60.5M | Sell |
192,078
-62,249
| -24% | -$18.7M | 0.26% | 84 |
|
|
2022
Q4 | $73.4M | Buy |
254,327
+352
| +0.1% | +$107K | 0.36% | 61 |
|
|
2022
Q3 | $73.5M | Sell |
253,975
-36,001
| -12% | -$10.4M | 0.38% | 58 |
|
|
2022
Q2 | $81.7M | Buy |
289,976
+11,537
| +4% | +$3.09M | 0.41% | 60 |
|
|
2022
Q1 | $72.7M | Sell |
278,439
-306,815
| -52% | -$72.8M | 0.29% | 89 |
|
|
2021
Q4 | $129M | Buy |
585,254
+305,091
| +109% | +$59.3M | 0.42% | 57 |
|
|
2021
Q3 | $50.8M | Sell |
280,163
-312,129
| -53% | -$60.9M | 0.19% | 130 |
|
|
2021
Q2 | $119M | Buy |
592,292
+86,264
| +17% | +$18M | 0.22% | 114 |
|
|
2021
Q1 | $109M | Buy |
506,028
+16,836
| +3% | +$3.7M | 0.22% | 116 |
|
|
2020
Q4 | $636M | Buy |
489,192
+192,756
| +65% | +$44.2M | 0.27% | 90 |
|
|
2020
Q3 | $80.7M | Buy |
296,436
+51,938
| +21% | +$14.3M | 0.24% | 95 |
|
|
2020
Q2 | $71M | Buy |
244,498
+145,258
| +146% | +$39.4M | 0.24% | 102 |
|
|
2020
Q1 | $23.6M | Sell |
99,240
-15,529
| -14% | -$3.56M | 0.2% | 119 |
|
|
2019
Q4 | $25.1M | Sell |
114,769
-481
| -0.4% | -$97.3K | 0.16% | 158 |
|
|
2019
Q3 | $19.5M | Buy |
115,250
+20,332
| +21% | +$3.6M | 0.14% | 174 |
|
|
2019
Q2 | $17.4M | Buy |
94,918
+19,020
| +25% | +$3.33M | 0.13% | 194 |
|
|
2019
Q1 | $14M | Buy |
75,898
+12,963
| +21% | +$2.39M | 0.11% | 223 |
|
|
2018
Q4 | $10.4M | Buy |
62,935
+28,069
| +81% | +$4.86M | 0.12% | 221 |
|
|
2018
Q3 | $6.72M | Buy |
34,866
+10,419
| +43% | +$1.86M | 0.05% | 368 |
|
|
2018
Q2 | $4.16M | Buy |
24,447
+4,834
| +25% | +$749K | 0.04% | 444 |
|
|
2018
Q1 | $3.2M | Sell |
19,613
-3,115
| -14% | -$509K | 0.03% | 473 |
|
|
2017
Q4 | $3.41M | Sell |
22,728
-6,429
| -22% | -$952K | 0.03% | 463 |
|
|
2017
Q3 | $4.43M | Buy |
29,157
+2,769
| +10% | +$417K | 0.04% | 420 |
|
|
2017
Q2 | $3.4M | Sell |
26,388
-978
| -4% | -$118K | 0.03% | 465 |
|
|
2017
Q1 | $2.99M | Sell |
27,366
-31,073
| -53% | -$2.74M | 0.03% | 543 |
|
|
2016
Q4 | $4.3M | Sell |
58,439
-17,535
| -23% | -$1.43M | 0.04% | 431 |
|
|
2016
Q3 | $6.63M | Sell |
75,974
-25,288
| -25% | -$2.39M | 0.08% | 286 |
|
|
2016
Q2 | $8.71M | Buy |
101,262
+6,055
| +6% | +$523K | 0.12% | 197 |
|
|
2016
Q1 | $7.57M | Buy |
95,207
+52,584
| +123% | +$4.76M | 0.13% | 209 |
|
|
2015
Q4 | $5.36M | Buy |
42,623
+14,759
| +53% | +$1.78M | 0.1% | 246 |
|
|
2015
Q3 | $2.9M | Sell |
27,864
-21,758
| -44% | -$2.8M | 0.06% | 357 |
|
|
2015
Q2 | $6.13M | Sell |
49,622
-9,435
| -16% | -$1.19M | 0.08% | 291 |
|
|
2015
Q1 | $6.97M | Buy |
59,057
+12,704
| +27% | +$1.52M | 0.09% | 257 |
|
|
2014
Q4 | $5.51M | Buy |
46,353
+37,171
| +405% | +$4.19M | 0.07% | 333 |
|
|
2014
Q3 | $1.03M | Sell |
9,182
-9,891
| -52% | -$942K | 0.04% | 509 |
|
|
2014
Q2 | $1.81M | Sell |
19,073
-1,377
| -7% | -$96.6K | 0.02% | 619 |
|
|
2014
Q1 | $1.45M | Sell |
20,450
-17,046
| -45% | -$1.35M | 0.02% | 567 |
|
|
2013
Q4 | $2.79M | Buy |
37,496
+16,520
| +79% | +$1.15M | 0.04% | 429 |
|
|
2013
Q3 | $1.59M | Sell |
20,976
-14,829
| -41% | -$1.18M | 0.03% | 567 |
|
|
2013
Q2 | $2.87M | Buy |
+35,805
| New | +$2.64M | 0.05% | 410 |
|
Other funds holding VRTX
VCM
VPM
KBC Group's VRTX Position: Q1 2026 in Review
KBC Group reduced its Vertex Pharmaceuticals (VRTX) stake by 9.9% in Q1 2026, selling an estimated $6.49M and leaving 127,208 shares worth $56.8M. The position accounts for 0.14% of the portfolio, ranked #139.
KBC Group first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $636M in Q4 2020. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- KBC Group held 127,208 shares of Vertex Pharmaceuticals worth $56.8M as of Q1 2026.
- KBC Group sold 13,912 Vertex Pharmaceuticals shares in Q1 2026, an estimated $6.49M.
- Vertex Pharmaceuticals made up 0.14% of KBC Group's portfolio in Q1 2026, its #139 holding.
- KBC Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- KBC Group's Vertex Pharmaceuticals position peaked at $636M in Q4 2020.
- 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.